Compounds > levodopa
Page last updated: 2024-08-17

levodopa and fluorodeoxyglucose f18

levodopa has been researched along with fluorodeoxyglucose f18 in 45 studies

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-19904 (8.89)18.7374
1990's9 (20.00)18.2507
2000's16 (35.56)29.6817
2010's14 (31.11)24.3611
2020's2 (4.44)2.80

Authors

AuthorsStudies
Adam, MJ; Ammann, W; Bergstrom, M; Harrop, R; Laihinen, A; Martin, WR; Rogers, JG; Ruth, TJ; Sayre, CI; Stoessl, AJ1
Firnau, G; Garnett, ES; Lang, AE; Nahmias, C; Talalla, A1
Adam, MJ; Ammann, W; Beattie, BL; Calne, DB; Harrop, R; Kamo, H; Li, DK; McGeer, EG; McGeer, PL; Tuokko, H1
Agid, Y; Baron, JC; Bustany, P; Collard, P; Comar, D; Rougemont, D1
Lang, AE1
Antoni, G; Bergström, M; Bjurling, P; Jacobson, GB; Långström, B; Matsumura, K; Onoe, H; Takechi, H; Watanabe, Y; Westerberg, G1
Hawkins, RA1
Calne, DB; Doudet, D; Hewitt, KA; Nugent, R; Olanow, W; Pate, BD; Perl, DP; Shinotoh, H; Snow, BJ1
Bressi, S; Caraceni, T; Cortelli, P; Fazio, F; Gentrini, S; Grassi, F; Perani, D; Savoiardo, M; Testa, D1
Hirato, M; Horikoshi, S; Ishihara, J; Ohye, C; Shibazaki, T1
Akiguchi, I; Fukuyama, H; Hanakawa, T; Kato, M; Kimura, J; Shibasaki, H1
Alterman, RL; Antonini, A; Beric, A; Dhawan, V; Eidelberg, D; Fazzini, E; Kazumata, K; Kelly, P; Moeller, JR; Sterio, D1
Damhaut, P; Dethy, S; Goldman, S; Hildebrand, J; Van Blercom, N; Wikler, D1
Imahori, Y; Kawano, H; Misawa, A; Sawada, T; Takeuchi, Y1
Dhawan, V; Eidelberg, D; Feigin, A; Fukuda, M; Jackson-Lewis, V; Mentis, MJ; Moeller, JR; Przedborski, S1
Berding, G; Brooks, DJ; Dengler, R; Fricke, H; Knapp, WH; Kolbe, H; Matthies, C; Nikkhah, G; Odin, P; Peschel, T; Samii, M; Shing, M; van Den Hoff, J1
Bombardieri, E; Chiti, A; De Deckere, E; Maccauro, M; Savelli, G1
Ghaemi, M; Heiss, WD; Herholz, K; Hilker, R; Sturm, V; Thiel, A; Voges, J1
Antenor, JA; Kotagal, V; McGee-Minnich, L; Moerlein, SM; Perlmutter, JS; Racette, BA; Videen, TO1
Asanuma, K; Bressman, SB; Carbon-Correll, M; Edwards, C; Eidelberg, D; Huang, C; Ma, Y; Moeller, JR; Raymond, D1
Hayashi, K; Honda, H; Kaneko, K; Kira, J; Koga, H; Kuwabara, Y; Nakagawa, M; Sasaki, M; Taniwaki, T1
Haginoya, K; Higano, S; Iinuma, K; Ishitobi, M; Kitamura, T; Nara, T; Onuma, A; Togashi, N; Wakusawa, K; Yokoyama, H1
Leenders, KL; van Beilen, M1
Asanuma, K; Dhawan, V; Edwards, C; Eidelberg, D; Feigin, A; Kaplitt, MG; Ma, Y; Mattis, P; Tang, C1
Guan, Y; Li, D; Shen, J; Sun, B; Zan, S; Zhao, Y; Zuo, C1
Aalto, S; Chang, JW; Lee, KO; Lee, MS; Lyoo, CH; Oh, SH; Rinne, JO1
Airas, L; Marttila, RJ; Paavilainen, T; Rinne, J1
Aalto, S; Bergman, J; Brück, A; Marttila, R; Rauhala, E; Rinne, JO1
Huang, Y; Jiang, X; Tang, A; Wik, G; Zhuo, Y1
Anders, S; Binkofski, F; Klein, C; Münte, T; Pohl, A; Pramstaller, P; Sack, B1
Goldstein, DS; Holmes, C; Sharabi, Y1
Eidelberg, D; Feigin, A; Niethammer, M1
Bourgeat, P; Coulthard, A; Crozier, S; Dowson, N; Fay, M; Gal, Y; Rose, S; Salvado, O; Thomas, P1
Loane, C; Niccolini, F; Politis, M1
Lewitt, PA; Mouradian, MM1
Appel-Cresswell, S; Dickson, DW; Dinelle, K; Farrer, MJ; McCormick, SE; McKenzie, J; Rajput, A; Rajput, AH; Robinson, CA; Silva, V; Sossi, V; Stoessl, AJ; Thompson, C; Vilariño-Güell, C1
Eggers, C; Eidelberg, D; Fink, GR; Holtbernd, F; Kracht, L; Ma, Y; Peng, S; Schwartz, F; Tang, CC; Timmermann, L1
Behr, J; Boehme, R; Buchert, R; Deserno, L; Gleich, T; Heinz, A; Katthagen, T; Pankow, A; Roiser, JP; Schlagenhauf, F1
Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sidransky, E; Stefani, A; Sullivan, P1
Ding, Z; Ge, J; Guo, S; Liu, F; Liu, Z; Tang, Y; Wang, J; Wang, Y; Wu, J; Wu, P; Zuo, C1
Eidelberg, D; Fujita, K; Ma, Y; Mattis, PJ; Peng, S; Sako, W; Skidmore, FM; Uluğ, AM; Vo, A1
Agorastos, S; Bimpisidis, Z; Cenci, MA; Dewey, SL; Eidelberg, D; Lerner, RP; Scherrer, S1
Chen, Y; Lian, Y; Wang, C; Wang, R; Zhang, Y1
Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL1
Bouillot, C; Chaib, S; Depoortere, R; Levigoureux, E; Newman-Tancredi, A; Vidal, B; Zimmer, L1

Reviews

5 review(s) available for levodopa and fluorodeoxyglucose f18

ArticleYear
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1986, Mar-15, Volume: 134, Issue:6

    Topics: Aged; Alzheimer Disease; Atrophy; Cerebellar Cortex; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen; Psychological Tests; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Water

1986
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4

    Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed

1995
Nuclear medicine imaging of neuroendocrine tumours.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12 Suppl 2

    Topics: 3-Iodobenzylguanidine; 5-Hydroxytryptophan; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed

2001
Functional neuroimaging in Parkinson's disease.
    Cold Spring Harbor perspectives in medicine, 2012, Volume: 2, Issue:5

    Topics: Antiparkinson Agents; Brain Diseases, Metabolic; Cognition Disorders; Disease Progression; Dopamine; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Levodopa; Lewy Bodies; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Psychomotor Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2012
Dyskinesias in Parkinson's disease: views from positron emission tomography studies.
    European journal of neurology, 2014, Volume: 21, Issue:5

    Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Humans; Levodopa; Parkinson Disease; Positron-Emission Tomography

2014

Trials

2 trial(s) available for levodopa and fluorodeoxyglucose f18

ArticleYear
PET evaluation of the relationship between D2 receptor binding and glucose metabolism in patients with parkinsonism.
    Annals of nuclear medicine, 2005, Volume: 19, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Tissue Distribution

2005
Network modulation in the treatment of Parkinson's disease.
    Brain : a journal of neurology, 2006, Volume: 129, Issue:Pt 10

    Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Cerebellum; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Humans; Levodopa; Linear Models; Male; Middle Aged; Motor Cortex; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Putamen; Subthalamic Nucleus; Treatment Outcome

2006

Other Studies

38 other study(ies) available for levodopa and fluorodeoxyglucose f18

ArticleYear
Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
    Advances in neurology, 1987, Volume: 45

    Topics: Adult; Aged; Blood Glucose; Brain; Caudate Nucleus; Cerebellum; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Levodopa; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed

1987
Positron tomography in dystonia.
    Advances in neurology, 1988, Volume: 50

    Topics: Brain; Circadian Rhythm; Deoxyglucose; Dystonia; Dystonia Musculorum Deformans; Fluorodeoxyglucose F18; Humans; Levodopa; Putamen; Tissue Distribution; Tomography, Emission-Computed

1988
Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1984, Volume: 47, Issue:8

    Topics: Antiparkinson Agents; Autoradiography; Blood Glucose; Brain; Deoxyglucose; Drug Therapy, Combination; Fluorodeoxyglucose F18; Humans; Kinetics; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed

1984
In vitro positron emission tomography (PET): use of positron emission tracers in functional imaging in living brain slices.
    Neuroscience research, 1995, Volume: 22, Issue:2

    Topics: Animals; Brain; Buffers; Carbon Radioisotopes; Culture Media; Deoxyglucose; Dopamine; Dopamine Antagonists; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Kinetics; Levodopa; Male; Neurotransmitter Agents; Organ Culture Techniques; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Tomography, Emission-Computed

1995
Pancreatic tumors: imaging with PET.
    Radiology, 1995, Volume: 195, Issue:2

    Topics: Adenocarcinoma; Carbon Radioisotopes; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Sensitivity and Specificity; Serotonin; Tomography, Emission-Computed

1995
MRI and PET studies of manganese-intoxicated monkeys.
    Neurology, 1995, Volume: 45, Issue:6

    Topics: Animals; Carbidopa; Corpus Striatum; Deoxyglucose; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Raclopride; Salicylamides; Substantia Nigra; Tomography, Emission-Computed

1995
Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Archives of neurology, 1995, Volume: 52, Issue:2

    Topics: Atrophy; Brain Diseases; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed

1995
Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
    Acta neurochirurgica. Supplement, 1995, Volume: 64

    Topics: Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Chorea; Deoxyglucose; Dyskinesia, Drug-Induced; Electrodes, Implanted; Energy Metabolism; Fluorodeoxyglucose F18; Globus Pallidus; Humans; Levodopa; Motor Neurons; Neural Pathways; Neurologic Examination; Parkinson Disease; Stereotaxic Techniques; Thalamic Nuclei; Tomography, Emission-Computed; Tremor

1995
[A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
    Rinsho shinkeigaku = Clinical neurology, 1996, Volume: 36, Issue:5

    Topics: Adult; Age of Onset; Brain; Deoxyglucose; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Parkinson Disease; Tomography, Emission-Computed

1996
Preoperative indicators of clinical outcome following stereotaxic pallidotomy.
    Neurology, 1997, Volume: 49, Issue:4

    Topics: Aged; Antiparkinson Agents; Brain; Electrophysiology; Female; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Postoperative Period; Stereotaxic Techniques; Tomography, Emission-Computed; Treatment Outcome

1997
Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:2

    Topics: Adult; Aged; Antiparkinson Agents; Basal Ganglia; Blood Glucose; Brain Mapping; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Motor Skills; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Tomography, Emission-Computed; Treatment Outcome

1998
Putaminal necrosis presenting with hemidystonia.
    Pediatric neurology, 2000, Volume: 22, Issue:3

    Topics: Antiparkinson Agents; Brain Diseases; Child; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Necrosis; Putamen; Tomography, Emission-Computed; Treatment Outcome

2000
Metabolic correlates of levodopa response in Parkinson's disease.
    Neurology, 2001, Dec-11, Volume: 57, Issue:11

    Topics: Aged; Blood Glucose; Brain; Brain Mapping; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Reference Values; Tomography, Emission-Computed

2001
Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:6

    Topics: Adult; Antiparkinson Agents; Case-Control Studies; Cerebral Cortex; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed

2001
Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET.
    Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:10

    Topics: Aged; Antiparkinson Agents; Brain Chemistry; Electric Stimulation Therapy; Fluorodeoxyglucose F18; Functional Laterality; Gait; Glucose; Humans; Levodopa; Male; Parkinson Disease; Radiopharmaceuticals; Subthalamic Nucleus; Tomography, Emission-Computed

2002
[18F]FDOPA PET and clinical features in parkinsonism due to manganism.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:4

    Topics: Adult; Antiparkinson Agents; Brain; Carbidopa; Drug Combinations; Female; Fluorodeoxyglucose F18; Gait; Humans; Levodopa; Magnetic Resonance Imaging; Manganese Poisoning; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals

2005
The metabolic pathology of dopa-responsive dystonia.
    Annals of neurology, 2005, Volume: 57, Issue:4

    Topics: Adult; Brain; Brain Mapping; Dystonia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Levodopa; Male; Parkinson Disease; Positron-Emission Tomography

2005
Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
    The Tohoku journal of experimental medicine, 2006, Volume: 209, Issue:2

    Topics: Administration, Oral; Antiparkinson Agents; Atrophy; Basal Ganglia; Carbidopa; Cerebellum; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Spinocerebellar Degenerations; Treatment Outcome

2006
Putamen FDOPA uptake and its relationship tot cognitive functioning in PD.
    Journal of the neurological sciences, 2006, Oct-25, Volume: 248, Issue:1-2

    Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Memory; Models, Biological; Neuropsychological Tests; Parkinson Disease; Problem Solving; Putamen; Tomography, Emission-Computed

2006
FDG-PET study of the bilateral subthalamic nucleus stimulation effects on the regional cerebral metabolism in advanced Parkinson disease.
    Acta neurochirurgica. Supplement, 2006, Volume: 99

    Topics: Antiparkinson Agents; Brain; Brain Mapping; Deep Brain Stimulation; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Follow-Up Studies; Functional Laterality; Humans; Informed Consent; Levodopa; Parkinson Disease; Positron-Emission Tomography; Preoperative Care; Radiography; Radiopharmaceuticals; Subthalamic Nucleus

2006
Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Nov-15, Volume: 22, Issue:15

    Topics: Adult; Aged; Antiparkinson Agents; Brain Mapping; Cerebral Cortex; Combined Modality Therapy; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neural Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Subthalamic Nucleus

2007
Methanol intoxication-induced nigrostriatal dysfunction detected using 6-[18F]fluoro-L-dopa PET.
    Neurotoxicology, 2008, Volume: 29, Issue:4

    Topics: Brain Diseases; Corpus Striatum; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Methanol; Middle Aged; Poisoning; Positron-Emission Tomography; Substantia Nigra

2008
A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen.
    Movement disorders : official journal of the Movement Disorder Society, 2009, May-15, Volume: 24, Issue:7

    Topics: Aged; Brain Mapping; Disease Progression; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Nonlinear Dynamics; Parkinson Disease; Positron-Emission Tomography; Postmortem Changes; Putamen; Time Factors

2009
Complementary acupuncture treatment increases cerebral metabolism in patients with Parkinson's disease.
    The International journal of neuroscience, 2009, Volume: 119, Issue:8

    Topics: Acupuncture Therapy; Aged; Antiparkinson Agents; Benserazide; Brain Chemistry; Combined Modality Therapy; Drug Combinations; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals

2009
Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele.
    Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 4

    Topics: Adult; Alleles; Analysis of Variance; Brain; Case-Control Studies; Executive Function; Face; Facial Expression; Family Health; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Levodopa; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Oxygen; Parkinson Disease; Pattern Recognition, Visual; Photic Stimulation; Positron-Emission Tomography; Recognition, Psychology; Self Report; Severity of Illness Index; Ubiquitin-Protein Ligases

2012
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.
    Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pure Autonomic Failure; ROC Curve

2012
Correlation of MRI-derived apparent diffusion coefficients in newly diagnosed gliomas with [18F]-fluoro-L-dopa PET: what are we really measuring with minimum ADC?
    AJNR. American journal of neuroradiology, 2013, Volume: 34, Issue:4

    Topics: Aged; Aged, 80 and over; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Dopamine Agents; Female; Fluorodeoxyglucose F18; Glioma; Humans; Levodopa; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals

2013
Predicting the development of levodopa-induced dyskinesias: a presynaptic mechanism?
    Neurology, 2014, May-06, Volume: 82, Issue:18

    Topics: Amantadine; Antiparasitic Agents; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Humans; Levodopa; Parkinson Disease; Positron-Emission Tomography; Presynaptic Terminals

2014
Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:13

    Topics: Aged; Aged, 80 and over; Brain; Carbon Isotopes; Dopamine Agents; Family Health; Fluorodeoxyglucose F18; Humans; Levodopa; Middle Aged; Molecular Chaperones; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Tetrabenazine

2014
Dopaminergic correlates of metabolic network activity in Parkinson's disease.
    Human brain mapping, 2015, Volume: 36, Issue:9

    Topics: Adult; Brain; Brain Mapping; Dopamine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals

2015
Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015, Jul-15, Volume: 35, Issue:28

    Topics: Adolescent; Adult; Conditioning, Operant; Corpus Striatum; Dopamine; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Oxygen; Positron-Emission Tomography; Prodromal Symptoms; Psychotic Disorders; Reaction Time; Reinforcement, Psychology; Young Adult

2015
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:9

    Topics: Autopsy; Catecholamines; Fluorodeoxyglucose F18; Humans; Levodopa; Neurodegenerative Diseases; Neurons; Parkinson Disease; Putamen; Synaptic Vesicles

2015
Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: Aged; Brain; Cerebral Cortex; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography

2016
Parkinson's disease-related network topographies characterized with resting state functional MRI.
    Human brain mapping, 2017, Volume: 38, Issue:2

    Topics: Adult; Aged; Antiparkinson Agents; Brain; Brain Mapping; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Levodopa; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Oxygen; Parkinson Disease; Positron-Emission Tomography; Reproducibility of Results; Rest

2017
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model.
    Neurobiology of disease, 2016, Volume: 96

    Topics: Analgesics; Animals; Antiparkinson Agents; Cerebrovascular Circulation; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Hemodynamics; Isoflurane; Ketamine; Levodopa; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Sympatholytics

2016
Hypnic Headache with Dopaminergic Neuron Dysfunction: New Insight from a Rare Case.
    Pain medicine (Malden, Mass.), 2019, 08-01, Volume: 20, Issue:8

    Topics: Benserazide; Brain; Cocaine; Dopamine Agents; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Drug Combinations; Fluorodeoxyglucose F18; Headache Disorders, Primary; Humans; Levodopa; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Putamen; Radiopharmaceuticals

2019
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Parkinsonism & related disorders, 2022, Volume: 101

    Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2022
Multimodal imaging study of the 5-HT
    NeuroImage. Clinical, 2023, Volume: 39

    Topics: Animals; Dyskinesias; Fluorodeoxyglucose F18; Levodopa; Multimodal Imaging; Parkinson Disease; Rats; Receptor, Serotonin, 5-HT1A; Serotonin

2023